Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 155 275 $ as of 30/08/2026

53 year
Health Technology
Consumer Services

Profile

Dr. Alexandra Kropotova is a Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. and an Independent Director at iBio, Inc. She is on the Board of Directors at iBio, Inc. Dr. Kropotova was previously employed as a VP-Global Specialty Research & Development by Teva Pharmaceuticals, Inc., a Vice President-Strategy & Head-Strategic Planning by Sanofi, and a Director & Head-Global Clinical Respiratory by Pfizer Inc. She received her MBA from Ohio University Graduate College and a doctorate degree from Pacific State Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/09/2026 41,853 ( 0.05% ) 155 275 $ 30/08/2026
31/08/2026 0 ( -.--% ) - $ 30/08/2026

Alexandra Kropotova active positions

CompaniesPositionStart
IBIO, INC. Director/Board Member 13/10/2020
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 05/06/2022

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Corporate Officer/Principal 31/05/2022
SANOFI Corporate Officer/Principal 31/12/2015
PFIZER INC. Director/Board Member 31/12/2006
See the detail of Alexandra Kropotova's experience

Training of Alexandra Kropotova

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova